Tale of Two Magnets: An Advanced Magnetic Targeting System
Source abstract
Abstract
Magnetic targeting strategies employ external magnet fields to manipulate magnetic nanoparticles (MNPs) remotely, aiming to enhance their accumulation and penetration in vivo, which have received increasing attention in drug-delivery systems over the past decades. However, this approach has not yet been successful in translational clinical studies, largely due to the low efficacy and uncontrollable distribution of MNPs. The standard magnetic targeting strategy uses a single magnet and, thus, suffers from rapid drop-off of the magnetic field and field gradient with increasing distance away from the magnet surface. As a result, magnetic targeting of MNPs is often limited to superficial regions of interest. As reported in this issue of ACS Nano, Andrew Tsourkas and his colleagues showed that a two-magnet configuration can solve this dilemma by introducing a constant field gradient between the magnets for advanced magnetic targeting. The custom-built two-magnet device evidenced greatly enhanced accumulation and penetration of MNPs in a solid tumor model, shedding new light on future design considerations of magnetic targeting systems.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Microfluidic and Bio-sensing Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, United States
Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, Biomaterials Research Center, School of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China
Funding
National Institute of Biomedical Imaging and Bioengineering
References (48)
Show source-provided references
1. 10.1038/nbt.333010.1038/nbt.3330 ↗
2. 10.1021/cr500463410.1021/cr5004634 ↗
3. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
4. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
5. 10.1021/acsnano.9b0392410.1021/acsnano.9b03924 ↗
6. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
7. 10.1073/pnas.101838210810.1073/pnas.1018382108 ↗
8. 10.3389/fphar.2017.0095210.3389/fphar.2017.00952 ↗
9. 10.1016/j.trecan.2018.02.00510.1016/j.trecan.2018.02.005 ↗
10. 10.1021/jacs.9b0462110.1021/jacs.9b04621 ↗
11. 10.1038/s41565-019-0485-z10.1038/s41565-019-0485-z ↗
12. 10.1002/adma.20180392610.1002/adma.201803926 ↗
13. 10.1002/adma.20160149810.1002/adma.201601498 ↗
14. 10.7150/thno.3165310.7150/thno.31653 ↗
15. 10.1021/acsnano.9b0566010.1021/acsnano.9b05660 ↗
16. 10.1021/jacs.8b0937410.1021/jacs.8b09374 ↗
17. 10.1021/acsnano.8b0504210.1021/acsnano.8b05042 ↗
18. 10.1021/jacs.8b0088410.1021/jacs.8b00884 ↗
19. 10.1063/1.198476510.1063/1.1984765 ↗
20. 10.1515/znc-1976-11-121910.1515/znc-1976-11-1219 ↗
21. Lübbe A. S. · Cancer Res. · 1996 · 56 · 4694
22. Lübbe A. S. · Cancer Res. · 1996 · 56 · 4686
23. 10.1517/1742524080266279510.1517/17425240802662795 ↗
24. 10.1021/acs.nanolett.6b0226110.1021/acs.nanolett.6b02261 ↗
25. 10.1021/acsnano.7b0003810.1021/acsnano.7b00038 ↗
26. 10.1038/ncomms1559410.1038/ncomms15594 ↗
27. 10.1016/j.tibtech.2011.03.00110.1016/j.tibtech.2011.03.001 ↗
28. 10.1016/j.addr.2008.03.01810.1016/j.addr.2008.03.018 ↗
29. 10.1007/s11426-017-9217-410.1007/s11426-017-9217-4 ↗
30. 10.1006/jsre.2000.603010.1006/jsre.2000.6030 ↗
31. 10.1073/pnas.100338810710.1073/pnas.1003388107 ↗
32. 10.7150/thno.1741110.7150/thno.17411 ↗
33. 10.7150/thno.2078110.7150/thno.20781 ↗
34. 10.1118/1.370277510.1118/1.3702775 ↗
35. 10.1038/srep3356710.1038/srep33567 ↗
36. 10.1038/ncomms900910.1038/ncomms9009 ↗
37. 10.1016/j.biomaterials.2010.03.03210.1016/j.biomaterials.2010.03.032 ↗
38. 10.1002/wnan.131110.1002/wnan.1311 ↗
39. 10.1016/j.jmmm.2005.01.08110.1016/j.jmmm.2005.01.081 ↗
40. Alexiou C. · Cancer Res. · 2000 · 60 · 6641
41. 10.1021/acs.nanolett.6b0312210.1021/acs.nanolett.6b03122 ↗
42. 10.1038/nmat343010.1038/nmat3430 ↗
43. 10.7150/thno.2660810.7150/thno.26608 ↗
44. 10.7150/thno.1372810.7150/thno.13728 ↗
45. 10.1038/s41467-019-09704-x10.1038/s41467-019-09704-x ↗
46. 10.1002/adma.20180456710.1002/adma.201804567 ↗
47. 10.7150/thno.2522010.7150/thno.25220 ↗
48. 10.1021/cr300068p10.1021/cr300068p ↗